A 35-year-old pregnant woman presents to the emergency department with progressive dyspnea and palpitations that have worsened during the last 3 weeks.
The FDA has released draft guidance documents for appropriate marketing communication on medical products and devices.
Learn about the comprehensive management of rheumatic heart disease with Jack Boyd, MD, clinical assistant professor of cardiothoracic surgery at Stanford University School of Medicine.
While mortality rates were similar between percutaneous coronary intervention and coronary artery bypass grafting in both EXCEL and NOBLE trials, the risk of major cardiovascular events was higher in PCI in NOBLE.
Experts say bioresorbable stents are "a few generations away" from being standard of care in interventional cardiology.
A composite end point of death, heart failure, new myocardial infarction, and revascularization was similar between the deferred stenting group and the conventional treatment group.
An overview of the groundbreaking technology that has shaped interventional cardiology.
Transcatheter aortic valve replacement continues to evolve as a treatment for patients with symptomatic severe aortic stenosis, as well as for younger, lower-risk patients.
Patent foramen ovale closure resulted in a lower recurrence of stroke in patients with cryptogenic stroke and high-risk PFO characteristics.
The FDA has approved a new size of the Masters Series Mechanical Heart Valve with Hemodynamic Plus Sewing Cuff for use in newborn patients with heart defects.
Abnormal glucose metabolism may be present in patients with undetected diabetes after percutaneous coronary intervention.
A shared decision-making program between patients with end-stage heart failure being considered for destination therapy left ventricular assist device and their caregivers was associated with improvement in patient knowledge.
Percutaneous closure of patent foramen ovale is not associated with a reduction in migraine headaches in patients with and without aura.
Thrombocytopenia at hospital admission may be an independent predictor for in-hospital mortality in patients with rheumatic heart disease undergoing valve replacement surgery.
Patients with multivessel coronary artery disease and diabetes may benefit more from coronary artery bypass grafting surgery vs percutaneous coronary intervention.
Endovascular strategy is associated with better survival rate and decreased hospital costs compared to open repair in ruptured abdominal aortic aneurysm.
Intravenous sodium bicarbonate is not superior to intravenous sodium chloride for reducing acute kidney injury during angiography.
No evidence shows efficacy of PCI procedures for patients with stable coronary artery disease with angina.
The Cardiology Advisor Articles
- FDA Reports Combination Hypertension Treatment Discontinued
- Automated Detection of Atrial Fibrillation Through Smartwatch Technology
- Cardiovascular Outcomes of SGLT-2i vs Other Glucose-Lowering Drugs in T2D
- Outcomes With Aspirin for Primary Prevention in Heart Failure, Type 2 Diabetes
- Machine Learning Shows Potential in Diagnosing Myocardial Infarction in Patients With Chest Pain
- Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time
- Pioglitazone Lowers Cardiovascular, Noncardiovascular Mortality in Diabetes
- Peripheral Artery Disease, DVT Risk May Increase With Varicose Veins
- Cardiorespiratory Fitness May Improve Executive Function in Mild Cognitive Impairment
- Preventing Chemotherapy-Related Cardiotoxicity in Breast Cancer
- Patent Foramen Ovale Characteristics May Predict Benefits of PFO Closure
- Low-Dose Triple Combo Therapy Effective in Hypertension
- Blood Pressure, Glucose Levels Worsened From the Great Recession
- Acute MI Hospital Mortality During Transcatheter Cardiovascular Therapeutics Meeting Dates
- A 64-Year-Old Woman With Colorectal Cancer Presents to ED With Severe Chest Pain